Stachydrine Hydrochloride

CAS No. 4136-37-2

Stachydrine Hydrochloride( —— )

Catalog No. M18531 CAS No. 4136-37-2

Stachydrine Hydrochloride is an effective component that mainly extracted from the leaf of Leonurussibiricus.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG 43 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Stachydrine Hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Stachydrine Hydrochloride is an effective component that mainly extracted from the leaf of Leonurussibiricus.
  • Description
    Stachydrine Hydrochloride is an effective component that mainly extracted from the leaf of Leonurussibiricus.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    4136-37-2
  • Formula Weight
    179.64
  • Molecular Formula
    C7H14ClNO2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 100 mg/mL (556.67 mM)
  • SMILES
    C[N+]1(CCC[C@H]1C(=O)O)C.[Cl-]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhao L, et al. . Int Immunopharmacol. 2017 May 9;48:102-109.
molnova catalog
related products
  • Pyrocatechol

    Pyrocatechol its sulfonic acid is often present in the urine of many mammals. Small amounts of catechol occur naturally in fruits and vegetables along with the enzyme polyphenol oxidase. Upon mixing the enzyme with the substrate and exposure to oxygen (as when a potato or apple is cut) the colorless catechol oxidizes to reddish-brown benzoquinone derivatives.

  • Burosumab

    Burosumab(KRN23) is a human monoclonal antibody targeting fibroblast growth factor 23 (FGF23) for the treatment of cutaneous-skeletal hypophosphatemic syndrome (CSHS) and tumor-induced osteochondrosis.

  • Swertiachoside B

    Swertiachoside B